^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SHR-A1904

    i
    Associations
    News
    Trials
    Company:
    EMD Serono, Jiangsu Hengrui Pharma
    Drug class:
    Topoisomerase I inhibitor, CLDN18.2-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials